Relationship of Blood Pressure to Cardiovascular Death: The Effects of Pulse Pressure in the Elderly
|
|
- May Barnett
- 5 years ago
- Views:
Transcription
1 Relationship of Blood Pressure to Cardiovascular Death: The Effects of Pulse Pressure in the Elderly MEI-LING T. LEE, PhD, BERNARD A. ROSNER, PhD, AND SCOTT T. WEISS, MD PURPOSE: To investigate the relationship of systolic and diastolic blood pressure to fatal myocardial infarction, fatal stroke and other death related to cardiovascular diseases (CVD). METHODS: The study was based on a prospective longitudinal study conducted by the Veterans Administration at the Boston Outpatient Clinic. Participants are male volunteers from the greater Boston area. Main outcome measures are fatal myocardial infarction, fatal stroke and other deaths related to cardiovascular diseases. The method of pooled logistic regression was used for statistical analysis. RESULTS: For younger men (age 21 59), after adjusting for effects of other risk factors, when systolic and diastolic blood pressure were considered separately, SBP was predictive of cardiovascular death (SBP: RR 1.23; 95% CI (1.05, 1.45) per 10 mmhg of increase), and DBP showed a nonsignificant positive trend in relation to cardiovascular death (DBP: RR 1.27; 95% CI (0.95, 1.69) per 10 mmhg of increase). For older men (age 60 85), when SBP and DBP were considered separately, SBP (RR 1.26; 95% CI (1.02, 1.55) per 15 mmhg of increase) was directly related, but DBP (RR 1.05; 95% CI (0.83, 1.32) per 8 mmhg of increase) was not related to cardiovascular death. However, for the elderly group, when SBP and DBP were considered jointly in the regression model, then the regression coefficient of DBP ( 0.018, p 0.30) was of approximately the same absolute magnitude as that of SBP ( 0.021, p 0.02) but opposite in sign. For younger men, when SBP and DBP were considered jointly, SBP ( 0.021, p 0.049) but not DBP ( 0.001, p 0.953) was positively related to cardiovascular death. CONCLUSIONS: We found that, for the elderly, pulse pressure (SBP-DBP) may be a more accurate predictor of cardiovascular death than either SBP or DBP alone. The relative risk per 35 mmhg of increase of pulse pressure, which equals the approximate interval from the 10th to the 90th percentile in the elderly group, is 2.1 with 95% CI (1.1, 3.8). In younger subjects, SBP, but not DBP, is an independent predictor of fatal CVD. Ann Epidemiol 1999;9: Elsevier Science Inc. All rights reserved. KEY WORDS: Logistic Regression, Longitudinal Data, Myocardial Infarction, Stroke. decade of age. This phenomenon of decreasing DBP for the elderly also has been reported by the Manitoba follow-up study (10) and the Framingham study (11). Therefore, pulse pressure, defined as SBP minus DBP, increases slowly up to age 60 but then rises rapidly with increasing age. In this paper, we discuss the use of pulse pressure, in comparison to SBP or DBP alone, in predicting fatal myocar- dial infarction, fatal stroke and other deaths related to CVD in the elderly. Other risk factors considered include age, body mass index (BMI Weight/Height 2 ), cholesterol level (mg/dl), diabetes, prior MI, prior stroke, and smoking status. The study cohort of the NAS consists of initially healthy men with age range initially between 21 to 80 in Risk factors were recorded at each visit from 1963 to INTRODUCTION Abnormal blood pressure has long been recognized as a major risk factor for the development of coronary artery disease, stroke, and other cardiovascular disease (CVD) outcomes in adults (1, 2). Isolated systolic hypertension is recognized as an important predictor of adverse cardiovascular events in the elderly (3 6). Isolated systolic hypertension is known to predict myocardial infarction (MI), stroke, and death from congestive heart failure (7, 8). In a previous analysis (9) of the Normative Aging Study (NAS) data, we noticed that while the mean systolic blood pressure (SBP) increased with age for all age groups, the mean diastolic blood pressure (DBP) increased with age only prior to age 57.5; after age 57.5 the DBP decreased by 1 2 mmhg per From the Channing Laboratory, Brigham and Women s Hospital and METHODS Harvard Medical School, Boston, Massachusetts, USA. Address reprint requests to: Dr. Mei-Ling T. Lee, Channing Laboratory/ Study Population BWH, Harvard Medical School, 181 Longwood Avenue, Boston, MA Received December 18, 1997; revised April 14, 1998; accepted May The NAS (2) is a longitudinal study of health and aging 19, established by the Veterans Administration (VA) at the 1999 Elsevier Science Inc. All rights reserved /99/$ see front matter 655 Avenue of the Americas, New York, NY PII S (98)
2 102 Lee et al. AEP Vol. 9, No. 2 RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD February 1999: Selected Abbreviations and Acronyms the hospital chart and the death certificate together. If BMI body mass index necessary the NAS record is reviewed and/or the primary CI confidence interval physician is contacted to resolve any problem with missing CVD cardiovascular diseases or incomplete data. Codings of these fatal endpoints are DBP diastolic blood pressure based on the International Classification of Diseases (9th ICD9CM International Classification of Diseases (9th revision) Revision) Clinical Modification (ICD9CM) such that Clinical Modification MI myocardial infarction cause-of-death (either primary, secondary, or other causes) NAS Normative Aging Study with code ranging from 410 to denotes acute myocar- RR relative risk dial infarction, denotes stroke, , 411 SBP systolic blood pressure 429.9, , and 795 denotes other cardiovascular re- VA Veterans Administration lated deaths. Risk factors considered initially include body mass index (BMI), SBP and DBP, age at visit, cholesterol level, smoking status, prior MI, prior stroke, and current diagnosis of diabetes Boston Outpatient Clinic in Community residents mellitus. Because BMI, SBP, DBP, smoking status, and from around the greater Boston area were contacted and cholesterol levels were used as covariates in the logistic volunteered to be screened according to specific health criteria, regression models, observations with missing information and those with chronic health conditions including on any of these covariates were excluded from the analysis asthma, chronic bronchitis, obesity, diabetes mellitus, and data set. Accordingly, from 1963 to 1992, a total of 4842 hypertension were excluded. The study cohort initially in- visits from 1828 subjects with visit age less than 60, and a cluded 2280 community-dwelling male volunteers from the total of 1772 visits from 897 subjects with visit age older greater Boston area who were years of age at en- than 60 were included in the observational study. Due to rollment. the low incidence of diabetes in this population (less than 1.5%), diabetes was excluded as a risk factor in the regression Eligibility models. Only initially healthy individuals who met screening criteria based on current medical status and medical history to investigate Statistical Methods nonpathologic aging were enrolled. Blood pressure Since the data set contains repeated measurements such as was measured by an examining physician using a standard BMI and cholesterol level, we consider the method of pooled mercury sphygmomanometer while the subject was seated. logistic regression (12) for our analysis. Treating each exami- Systolic blood pressure and (SBP) and fifth-phase diastolic nation interval as a mini follow-up study, this method pools blood pressure (DBP) were measured to the nearest 2 mmhg, repeated observations of all time intervals. and the average of right and left arm values was used in The pooled person-visit data from the NAS were assemthese analyses. All physicians are trained annually in the bled as follows. Assume that subject i has v recorded visits. blood pressure measurement protocol. It is the same protocol Let Y i,j denote the indicator variable for fatal CVD event that has been used for the 30 years of the study. These subjects for subject i at visit j. Hence, Y i, j 0 for j 1,...,v. If were examined every 5 years before age 52, and every 3 years either fatal MI, fatal stroke or any other cardiovascular after age 52. The examination of subjects continues at present. related death is recorded after the last visit, then we define The longitudinal data were not equally spaced due to design; Y i,v 1 1; otherwise, Y i,v 1 0. Corresponding to the outalso subjects did not always return at the date of their come variable Y i,j is the covariate vector X ij (x ij1,...,x ijp ) t, scheduled visits according to the protocol. Thus the data denoting p risk factors observed at the j th visit. Given risk were not equally spaced even within the 52 and 52 factors X ij at the j th visit, j 1,...,v, let p i,j 1 Prob(Y i,j 1 age range, respectively. To eliminate possible confounding 1 X ij ) denote the conditional probability that subject i has effects of medication use, we restrict our attention to the a fatal MI, fatal stroke or other cardiovascular deaths after subcohort of those subjects who have never been treated with visit j. anti-hypertensive medication during the course of the study. For the logistic regression model, define, for j 1,...,v, Measurements The endpoints of interest are fatal MI, fatal stroke, and other deaths related to CVD. All death certificates and hospital charts are reviewed by a specially trained research nurse supervised by a physician to accurately determine the cause of death. NAS coded cause of death is not simply based on the death certificate but on a complete review of logit p i,j 1 log p i,j 1 1 p i,j 1 0 r k 1 k x ijk To investigate the relationship of blood pressure measurements with fatal cardiovascular outcomes, we ran a set of four logistic regression models. In these four regression models we included (a) SBP alone, (b) DBP alone, (c) both SBP and DBP, and (d) pulse pressure as a representation of blood
3 AEP Vol. 9, No. 2 February 1999: Lee et al. RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD 103 TABLE 1. Summary of frequencies and percentages of former and current smoking status by age Summary statistics of risk factors mean (standard deviation) at current visit a Summary of smoking status observed frequencies [row percent] Current Current Pulse Former smoker smoker Age at visit N b SBP DBP pressure BMI Cholesterol smoker 1 24/day 25 /day (10.22) (7.41) (9.18) (2.98) (43.07) [18.3%] [38.2%] [22.1%] (11.22) (8.07) (8.53) (2.88) (46.03) [31.9%] [27.2%] [19.9%] (11.87) (7.77) (8.65) (2.99) (46.48) [41.0%] [19.5%] [13.8%] (14.49) (8.57) (10.70) (3.20) (45.08) [48.3%] [12.1%] [10.8%] (16.03) (8.60) (12.47) (3.28) (43.54) [57.1%] [7.5%] [4.8%] (17.99) (8.83) (15.24) (3.16) (40.32) [57.3%] [5.2%] [1.8%] (19.02) (10.36) (15.89) (3.29) (39.47) [42.4%] [1.5%] [0.0%] a Excluding subjects treated with anti-hypertensive medication. b Total number of person visits: 1828 subjects have visits at age 60; 897 subjects have visits at age 60. pressure status, respectively. For each model, we included of cardiovascular related diseases at age less than 60 (36 the following covariates: BMI, total cholesterol level, prior died of MI, 3 of stroke, 18 of asymptomatic ischemic heart MI, prior stroke, a dichotomous variable for former smoking, disease with hypertensive disease, and 14 of other cardiovastwo dichotomous variables indicating current smokers num- cular disease). ber of cigarettes per day (1 24 cigarettes per day, 25 Table 1 gives summary statistics of the means and stancigarettes per day, respectively), and indicator variables of dard deviations for SBP and DBP, pulse pressure, BMI, and age at visit in 5-year groups. cholesterol level by age at current visit. For this table, the Since it was apparent in a preliminary analysis that the same subject may be included in different age intervals. It relationship of blood pressure to CVD death was different can be seen that the relationship between both mean SBP for subjects with age less than 60 years old than for subjects and DBP versus age is not linear. The standard deviation who are 60 years and older at a given visit, to control for of both SBP and DBP tend to rise with age. A summary of the effect of aging, separate analyses were presented for frequencies and percentages of former and current smoking these two age groups. status by age is also shown in Table 1. Over 50% of the men had smoked at some time in their lives, but only 20% of year-old men were current smokers with the percent RESULTS of current smoking declining sharply with age. Demographic Data For the younger people, over 10% of them smoked 25 or more cigarettes per day. Less than 5% of the elderly (age Of the selected study participants, the age distribution at 60 and up) smoked 25 or more cigarettes per day. their baseline visits has a range from 20 to 80. The mean Percentile distributions of SBP, DBP, and pulse pressure actual age at each subject s initial visit is 43 years old with by age group are presented in Table 2. The standard deviaa standard deviation of When the study began, 77% tion of SBP, DBP, and pulse pressure are approximately 15 of subjects were years old, 17% were years old, mmhg, 8 mmhg, and 10 mmhg, respectively. Furthermore, and 6% were Except for one person who had eight the approximate range from the 10th to the 90th percentile visits, subjects have up to seven visits. Over 80% of subjects of pulse pressure in the elderly group is 35 mmhg. have two or more visits. At the baseline visit, 33% of the subjects were former smokers and 40% of the subjects were current smokers. 64 of the 897 (7.13%) subjects with age Regression Results 60 and up at visits died of cardiovascular related diseases Tables 3 and 4 present pooled logistic regression results for (29 died of MI, 5 of stroke, and 30 of other cardiovascular subjects with age less than 60 and for subjects with age 60 disease including vascular heart disease, pericardial disease, and older, respectively. cardiomyopathy and pulmonary heart disease). For subjects Risk factors including BMI, total cholesterol, age group, younger than 60 at any visit, 71 of the 1828 (3.88%) died prior MI, and smoking status, are included in each of Models
4 104 Lee et al. AEP Vol. 9, No. 2 RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD February 1999: TABLE 2. Percentiles of SBP, DBP, and pulse pressure; Normative Aging Study: ; excluding subjects on anti-hypertensive medication SBP SBP SBP SBP SBP SBP SBP SBP SBP Age N Q1 Q5 Q10 Q25 Q50 Q75 Q90 Q95 Q DBP DBP DBP DBP DBP DBP DBP DBP DBP Q1 Q5 Q10 Q25 Q50 Q75 Q90 Q95 Q PulseP PulseP PulseP PulseP PulseP PulseP PulseP PulseP PulseP Q1 Q5 Q10 Q25 Q50 Q75 Q90 Q95 Q In addition to these risk factors, Model 1 includes SBP, the same absolute magnitude with SBP being the dominant Model 2 includes DBP, Model 3 includes both SBP and DBP, predictor of CVD death. On the other hand, unlike the elderly and Model 4 includes the pulse pressure as representation of group, total cholesterol and indicator variables for current blood pressure status, respectively. For the elderly, prior smoking status are significant for predicting fatal CVD for stroke is also included in Models 1 4 as a risk factor. subjects with visit age less than 60 years old. For the elderly, when SBP and DBP are considered separately, the regression coefficients are (p 0.033) for SBP in Model 1, and (p 0.689) DISCUSSION for DBP in Model 2, respectively. When SBP and DBP were both included in Model 3, the regression coefficients are We utilized the method of pooled logistic regression to (p 0.019) for SBP, and analyze longitudinal data concerning the relationship of (p 0.303) for DBP. Notice that, in this case, the regression SBP and DBP and other cardiovascular risk factors to fatal coefficients for SBP and DBP are of approximately the same CVD in the NAS. We found that there was a significant absolute magnitude but opposite in sign. When pulse pressure effect of pulse pressure in predicting fatal cardiovascular (SBP-DBP) was used in Model 4, it was significant with regrespersons outcomes in the elderly (age 60 and up). Conversely, for sion coefficient (p 0.017). Table 4 shows under age 60, only systolic blood pressure was a that, for the elderly, replacing the two variables SBP and DBP significant predictor of fatal CVD. (Model 3) by a single pulse pressure variable (Model 4) not In a previous analysis (9) of the NAS data set we noticed only provided about the same log likelihood, but reduced the that the relationship between both mean SBP and DBP, degrees of freedom by one. Hence we conclude that, for when plotted against age, was not linear. Specifically, mean subjects age 60 and older, pulse pressure has significant SBP increased by 0 1 mmhg per decade prior to age 47.5, effects in predicting fatal CVD, after adjusting for other and 2 7 mmhg per decade after 47.5; mean DBP increased possible confounders. In addition, prior MI and prior stroke by 1 2 mmhg per decade prior to age Subjects entering are significant predictors of fatal CVD for the elderly. the study at age showed slight increases in mean Table 3 presents regression results based on subjects less DBP after age 57.5, while subjects entering the study after than 60 years old. Although pulse pressure is significant in age 52.5 showed decreases of 1 2 mmhg per decade. Similar Model 4, when SBP and DBP were considered jointly in Model results on the decrease of DBP in elderly men have been 3, the regression coefficient of DBP and SBP were not of reported in the Manitoba Study (10) for 3983 Canadian
5 AEP Vol. 9, No. 2 February 1999: Lee et al. RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD 105 TABLE 3. Logistic regression analysis: Fatal CVD on selected cardiovascular risk factors; from 1828 subjects less than 60 years old Coefficient Model 1A: Model 2A: Model 3A: with Model 4A: pulse (p-value) with SBP only with DBP only both SBP & DBP pressure (BP-DBP) Intercept (0.000) (0.000) (0.000) (0.000) SBP (0.010) (0.049) DBP (0.109) (0.953) SBP-DBP (0.032) BMI (0.945) (0.994) (0.953) (0.808) Total cholesterol (0.009) (0.009) (0.009) (0.007) Current smoker /day (0.015) (0.014) (0.016) (0.023) Current smoker /day (0.001) (0.000) (0.001) (0.001) Former smoker (0.788) (0.770) (0.790) (0.828) Previous nonfatal MI (0.056) (0.053) (0.056) (0.060) Age (0.737) (0.755) (0.736) (0.716) Age (0.594) (0.641) (0.592) (0.560) Age (0.169) (0.182) (0.169) (0.154) Age (0.044) (0.046) (0.044) (0.038) Age (0.187) (0.157) (0.187) (0.162) 2logL d.f Reference age group: age 30 34; reference smoking group: non-smoking. Subjects never on anti-hypertensive medication; 71 events out of 4842 person visits. the analyses. (For the elderly, the relative risk per 35 mmhg increase in pulse pressure was 2.0 with 95% CI (1.2, 3.3)). The reasons for a reduction in DBP after age 60 have been attributed to a variety of different causes. One hypothesis is that an age-related decrease in cardiac output is the cause for the fall in DBP of age greater than 60, but this is inconsis- tent with the rise of SBP with age greater than 60. Franklin and colleagues (14) suggest that, after the sixth decade of life, increasing pulse pressure and decreasing DBP are surrogate measurements for large artery stiffness. The most likely explanation for the fall of DBP after age 60 is decreased compliance of large arteries (15 17). It is worth noting the mechanism by which stiffening of the proximal aorta may contribute to cardiac disease. Such stiffening will result in an increase in systolic blood pressure which in turn will result in increased left ventricular afterload and resultant left ventricular hypertrophy. In addition, the stiffening will lower diastolic blood pressure, re- men over a 40-year period between 1948 and 1988, and in the Framingham Heart Study (3) for 2036 subjects (890 men and 1146 women) in a population-based cohort. For subjects in the Manitoba study, DBP fell after age 55. In the Framingham study, a similar fall of DBP was noted after age 60. Thus for the elderly group the pulse pressure tended to increase with age. Our findings that pulse pressure, rather than systolic or diastolic pressure alone, was the best predictor of adverse cardiovascular events in the elderly is consistent with a known correlation of SBP with DBP (13) and, also, with the concept that large artery elasticity is the primary manifestation of a generalized arthrosclerotic process. To avoid the possible confounding effects of medication use, we eliminated all subjects who ever were on antihypertensive medications. However, we repeated the analysis by including subjects who received anti-hypertensive medication during the course of the study and obtained similar results for all
6 106 Lee et al. AEP Vol. 9, No. 2 RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD February 1999: TABLE 4. Logistic regression analysis: Fatal CVD on selected cardiovascular risk factors; from 897 subjects 60 years of age Model 3: Model 4: Coefficient Model 1: Model 2: with both pulse pressure (p-value) with SBP only with DBP only SBP & DBP (SBP-DBP) Intercept (0.001) (0.016) (0.005) (0.001) SBP (0.033) (0.019) DBP (0.689) (0.303) SBP-DBP (0.017) BMI (0.178) (0.209) (0.242) (0.247) Total cholesterol (0.113) (0.091) (0.110) (0.108) Current smoker /day (0.684) (0.723) (0.747) (0.757) Current smoker /day (0.224) (0.230) (0.260) (0.264) Former smoker (0.828) (0.722) (0.869) (0.871) Previous nonfatal MI (0.024) (0.025) (0.025) (0.026) Previous nonfatal stroke (0.030) (0.046) (0.029) (0.030) Age (0.464) (0.560) (0.433) (0.432) Age (0.599) (0.415) (0.694) (0.699) Age (0.248) (0.101) (0.347) (0.351) Age 80 and up (0.009) (0.004) (0.020) (0.020) 2log likelihood d.f Reference age group: age 60 64; reference smoking group: non-smoking. Subjects never on anti-hypertensive medication; 64 events out of 1772 person visits. sulting in decreased coronary artery driving pressure and decreased perfusion. A widening pulse pressure may be more predictive of cardiac risk than either SBP or DBP alone as both will increase cardiac work and the risk of heart failure and myocardial infarction. Benetos and colleagues (18) have confirmed a relationship of widening pulse pressure to increased cardiovascular mortality in 19,083 men years old followed for an average of 20 years. Similar results have been reported previously by Madhavan and colleagues (19), and by the SAVE investigators (20). One of the strengths of our investigation is that it is longitudinal and considers some of the relevant covariates influencing cardiovascular risk. An additional strength is the length of follow-up and the ability to track age-related blood pressure trends over 30 years of time. There are two potential limitations to the current investigation. First, our population is predominantly Caucasian and thus, we are unable to make any comments concerning African-American or other ethnic groups. The second limitation is that the NAS is solely male and, hence, we have no information on female trends in blood pressure and their influence on cardiovascular risk. These data do support the conclusion that, in elderly subjects age 60 or above, pulse pressure is a more accurate predictor than either systolic or diastolic pressure alone in predicting cardiovascular deaths. However, in younger subjects with age less than 60, SBP was a more important predictor of fatal CVD then DBP or pulse pressure. The research is supported in part by grant HL of the National Institutes of Health. The Normative Aging Study is sponsored by the Health Services Research and Development Service of the Department of Veterans Affairs. We thank Dr. Stanley Franklin for helpful comments and Soma Datta for programming assistance.
7 AEP Vol. 9, No. 2 February 1999: Lee et al. RELATIONSHIP OF PULSE PRESSURE TO FATAL CVD Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel REFERENCES WB, et al. Hemodynamic patterns of age-related changes in blood Joint National Committee. The 1988 Report of the Joint Na- pressure: The Framingham Heart Study. Circulation. 1997;96: tional Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1988;148: D Agostino RB, Lee M-L, Belanger AJ, Cupples LA, Anderson K, 2. Cassano P, Segal M, Vokonas P, Scott W. Body fat distribution, blood Kannel WB. Relation of pooled logistic regression to time dependent pressure, and hypertension: A prospective cohort study of men in the Cox regression analysis: The Framingham Heart Study. Statist Med. normative aging study. Ann Epidemiol. 1990;1: ;(9): Kannel WB, Gordon P, Schwartz MJ. Systolic versus diastolic blood 13. Kannel WB, Wolfe PA, McGee DL, Dawber TR, McNamara P, Castelli pressure in risk of coronary heart disease. The Framingham Study. WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Amer J Cardial. 1971;27: Framingham Study. JAMA. 1981;245: Gifford RW Jr. Are systolic/diastolic and isolated systolic hypertension 14. Franklin SS, Sutton-Tyrrel K, Belle SH, Weber MA, Kuller LH. The risk factors for the elderly? Geriatrics. 1989;44: importance of pulsatile components of hypertension in predicting ca- rotid stenosis in older adults. J Hypert. 1997;15: Bassadi BM, Furberg CD, Kuller LH, Borhani NO, Rautaharju PM, 15. Safar ME. Pulse pressure and essential hypertension: Clinical and O Leary DH, et al. Isolated systolic hypertension and subclinical cardiotherapeutic implications. J Hypert. 1989;7: vascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA. 1992;268: Franklin SS, Weber MA. Measuring hypertensive cardiovascular risk: The cardiovascular overload concept. Am Heart J. 1994;128: Kannel WB. Blood pressure as a cardiovascular risk factor: Prevention and Treatment. JAMA. 1996;275: Franklin SS. The concept of vascular overload in hypertension. Cardiol Clin. 1995;13: Perry HM Jr, Smith WM, McDonald RH, Black B, Cutler JA, Furgberg CD, et al. Morbidity and mortality in the systolic hypertension in the 18. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard J-L, Ducimetiere elderly program (SHEP) pilot study. Stroke. 1989;20:4 13. P, et al. Pulse pressure: A predictor of long-term cardiovascular mortal- ity in a French male population. Hypertension. 1997;30: Kannel WB, Wolfe PA, Verter J, McNamara PM. Epidemiologic assess- 19. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse ment of the role of blood pressure in stroke. JAMA. 1996;276: pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23: Lee M-LT, Rosner BA, Vokonas, PS, Weiss, ST. Longitudinal analysis 20. Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltof adult male blood pressure: The Normative Aging Study, man EM, et al. Sphygmomanometrically determined pulse pressure is J Epidemiol Biostat. 1996;1: a powerful independent predictor of recurrent events after myocardial 10. Tate RB, Manfreda J, Krahn AD, Cuddy TE. Tracking of blood pressure infarction in patients with impaired left ventricular function. SAVE over a 40-year period in the University of Manitoba follow-up study. Investigators. Survival and Ventricular Enlargement. Circulation. 1997; Am J Epidemiol. 1995;142: :
Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?
Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? The Framingham Heart Study Stanley S. Franklin, MD; Shehzad A. Khan, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Daniel Levy,
More informationBlood pressure (BP) is an established major risk factor for
Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates The Chicago Heart Association Detection Project in Industry Study Katsuyuki
More informationStroke A Journal of Cerebral Circulation
Stroke A Journal of Cerebral Circulation JULY-AUGUST VOL. 7 1976 NO. 4 Components of Blood Pressure and Risk of Atherothrombotic Brain Infarction: The Framingham Study WILLIAM B. KANNEL, M.D., THOMAS R.
More informationAnalyzing diastolic and systolic blood pressure individually or jointly?
Analyzing diastolic and systolic blood pressure individually or jointly? Chenglin Ye a, Gary Foster a, Lisa Dolovich b, Lehana Thabane a,c a. Department of Clinical Epidemiology and Biostatistics, McMaster
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More informationStroke is the third leading cause of death in the
Probability of Stroke: A Risk Profile From the Framingham Study Philip A. Wolf, MD; Ralph B. D'Agostino, PhD; Albert J. Belanger, MA; and William B. Kannel, MD A health risk appraisal function has been
More informationEpidemiology/Population
Epidemiology/Population Does Low Diastolic Blood Pressure Contribute to the Risk of Recurrent Hypertensive Cardiovascular Disease Events? The Framingham Heart Study Stanley S. Franklin, Sohum S. Gokhale,
More informationBaldness and Coronary Heart Disease Rates in Men from the Framingham Study
A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart
More informationDespite the acknowledged importance of hypertension as
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? The Framingham Heart Study Stanley S. Franklin, MD; Martin G. Larson, ScD; Shehzad A. Khan, BS; Nathan D. Wong, PhD;
More informationPulse pressure as a haemodynamic variable in systolic heart failure Petrie, Colin James
University of Groningen Pulse pressure as a haemodynamic variable in systolic heart failure Petrie, Colin James IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationTHE PREVALENCE OF CONGESTIVE
ORIGINAL CONTRIBUTION Increased Pulse Pressure and Risk of Heart Failure in the Elderly Claudia U. Chae, MD Marc A. Pfeffer, MD, PhD Robert J. Glynn, ScD Gary F. Mitchell, MD James O. Taylor, MD Charles
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationCardiovascular disease, which remains the leading cause
Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients Stéphane Laurent, Pierre Boutouyrie, Roland Asmar, Isabelle Gautier, Brigitte Laloux, Louis
More informationChanges in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease
...SYMPOSIUM PROCEEDINGS... Changes in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease Based on a presentation by Joseph L. Izzo, Jr., MD Presentation Summary Changes in systolic
More informationJournal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00687-2 Pulse
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More information3 Aging, Arterial Stiffness,
Chapter 3 / Mechanisms of Hypertension 23 3 Aging, Arterial Stiffness, and Systolic Hypertension Joseph L. Izzo, Jr., MD CONTENTS INTRODUCTION POPULATION STUDIES PATHOPHYSIOLOGY NONINVASIVE MEASUREMENT
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationPrediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal
Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationAlthough the association between blood pressure and
Two-Year Changes in Blood Pressure and Subsequent Risk of Cardiovascular Disease in Men Howard D. Sesso, ScD, MPH; Meir J. Stampfer, MD, DrPH; Bernard Rosner, PhD; J. Michael Gaziano, MD, MPH; Charles
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationdoi: /01.HYP
Influence of Heart Rate on Mortality in a French Population: Role of Age, Gender, and Blood Pressure Athanase Benetos, Annie Rudnichi, Frédérique Thomas, Michel Safar and Louis Guize Hypertension. 1999;33:44-52
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationIsolated Systolic Hypertension in the elderly. Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg
Isolated Systolic Hypertension in the elderly Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg Case no 1 Man aged 75, from Kosovo, in CH since 1.5 years Former smoker (45 PY) BP:
More informationCan Arterial Stiffness Be Reversed? And If So, What Are the Benefits?
...SYMPOSIUM PROCEEDINGS... Can Arterial Stiffness Be Reversed? And If So, What Are the Benefits? Based on a presentation by Michel E. Safar, MD Presentation Summary Systolic and diastolic blood pressure
More informationDiastolic hypertension, defined as a diastolic blood pressure
Hypertension Predictors of New-Onset Diastolic and Systolic Hypertension The Framingham Heart Study Stanley S. Franklin, MD; Jose R. Pio, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Eric P. Leip, MS;
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationCVD risk calculation
CVD risk calculation Cardiovascular disease (CVD) is the most common cause of death in Alberta, accounting for nearly one third (31%) of the overall deaths (1). The majority (90%) of the CVD cases are
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationORIGINAL INVESTIGATION. Calcium Antagonists and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study
ORIGINAL INVESTIGATION s and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study Vivian M. Abascal, MD; Martin G. Larson, ScD; Jane C. Evans, MPH; Ana T. Blohm, BA; Kim Poli,
More informationArterial function and longevity Focus on the aorta
Arterial function and longevity Focus on the aorta Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Secrets of longevity Secrets of longevity Unveiling
More informationDr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.
Original Article In hypertensive patients measurement of left ventricular mass index by echocardiography and its correlation with current electrocardiographic criteria for the diagnosis of left ventricular
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 N OVEMBER 1, 2001 NUMBER 18 IMPACT OF HIGH-NORMAL BLOOD PRESSURE ON THE RISK OF CARDIOVASCULAR DISEASE
More informationUsing Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly
Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama
More informationThe role of obesity as an independent risk factor for
AJH 2002; 15:538 543 The Relationship Between Body Mass Index and Pulse Pressure in Older Adults With Isolated Systolic Hypertension David Martins, Naureen Tareen, Deyu Pan, and Keith Norris Background:
More informationMany observational studies evaluating the changing pattern
Effect of Aging on the Prognostic Significance of Ambulatory Systolic, Diastolic, and Pulse Pressure in Essential Hypertension Rajdeep S. Khattar, BM, MRCP; John D. Swales, MA, MD, FRCP; Caroline Dore,
More informationa Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008
1072 Original article Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality Frédérique Thomas
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationORIGINAL INVESTIGATION. Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons
Elevated Midlife Blood Increases Stroke Risk in Elderly Persons The Framingham Study ORIGINAL INVESTIGATION Sudha Seshadri, MD; Philip A. Wolf, MD; Alexa Beiser, PhD; Ramachandran S. Vasan, MD; Peter W.
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationHigh-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study
22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if
More informationHypertension in Adults Across the Age Spectrum
ORIGINAL CONTRIBUTION Hypertension in Adults Across the Age Spectrum Current Outcomes and Control in the Community Donald M. Lloyd-Jones, MD, ScM Jane C. Evans, DSc Daniel Levy, MD ELDERLY PERSONS ARE
More informationPrognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
(2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationDirector of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016
The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular
More informationSmoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol
Atherosclerosis 190 (2007) 306 312 Smoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol Sun Ha Jee a,b,c,, Jungyong Park b, Inho Jo d, Jakyoung Lee a,b, Soojin
More informationPulse pressure (PP) is a well-established marker of cardiovascular
Different Prognostic Impact of 24-Hour Mean Blood Pressure and Pulse Pressure on Stroke and Coronary Artery Disease in Essential Hypertension Paolo Verdecchia, MD; Giuseppe Schillaci, MD; Gianpaolo Reboldi,
More informationESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study
ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationPatients with isolated systolic hypertension (ISH)
AJH 2001; 14:798 803 Association of Increased Pulse Pressure With the Development of Heart Failure in SHEP John B. Kostis, Janet Lawrence-Nelson, Rajiv Ranjan, Alan C. Wilson, William J. Kostis, and Clifton
More informationATRIAL FIBRILLATION (AF) IS
ORIGINAL CONTRIBUTION Pulse Pressure and Risk of New-Onset Atrial Fibrillation Gary F. Mitchell, MD Ramachandran S. Vasan, MD Michelle J. Keyes, MA Helen Parise, ScD Thomas J. Wang, MD Martin G. Larson,
More informationBIOPHYSICAL PROFILE OF BLOOD PRESSURE IN SCHOOLCHILDREN
BIOPHYSICAL PROFILE OF BLOOD PRESSURE IN SCHOOLCHILDREN M. Verma J. Chhatwal S.M. George ABSTRACT The study was conducted in an industrial and prosperous city of Punjab to evaluate the biophysical profile
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationThe Impact of Diabetes Mellitus and Prior Myocardial Infarction on Mortality From All Causes and From Coronary Heart Disease in Men
Journal of the American College of Cardiology Vol. 40, No. 5, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02044-2
More informationAntihypertensive Drug Therapy and Survival by Treatment Status in a National Survey
1-28 Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey Richard J. Havlik, Andrea Z. LaCroix, Joel C. Kleinman, Deborah D. Ingram, Tamara Harris, and Joan Cornoni-Huntley
More informationObesity, diabetes and cognitive deficit: The Framingham Heart Study
Neurobiology of Aging 26S (2005) S11 S16 Obesity, diabetes and cognitive deficit: The Framingham Heart Study Merrill F. Elias a,b,, Penelope K. Elias a,b, Lisa M. Sullivan a,c, Philip A. Wolf d, Ralph
More informationORIGINAL INVESTIGATION. Profile for Estimating Risk of Heart Failure
ORIGINAL INVESTIGATION Profile for Estimating Risk of Heart Failure William B. Kannel, MD, MPH; Ralph B. D Agostino, PhD; Halit Silbershatz, PhD; Albert J. Belanger, MS; Peter W. F. Wilson, MD; Daniel
More informationImproved control for confounding using propensity scores and instrumental variables?
Improved control for confounding using propensity scores and instrumental variables? Dr. Olaf H.Klungel Dept. of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences
More informationThe importance of arterial blood pressure (BP) as a
AJH 2005; 18:1463 1467 Pulse Pressure Predicts Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus John R. Cockcroft, Ian B. Wilkinson, Marc Evans, Philip McEwan, John R. Peters, Steve Davies,
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More information9 STUDY OF PR INTERVAL IN FEMALES OF DIFFERENT AGE GROUPS Swati Jangam 1,Manjunatha S 2, Vijaynath 3, Veena H C 4 1: Assistant nprofessor, department
9 STUDY OF PR INTERVAL IN FEMALES OF DIFFERENT AGE GROUPS Swati Jangam 1,Manjunatha S 2, Vijaynath 3, Veena H C 4 1: Assistant nprofessor, department of Physiology, Khaja Banda Nawaz institute of Medical
More informationDoes Body Mass Index Adequately Capture the Relation of Body Composition and Body Size to Health Outcomes?
American Journal of Epidemiology Copyright 1998 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 147, No. 2 Printed in U.S.A A BRIEF ORIGINAL CONTRIBUTION Does
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationUniversity of Groningen. Isolated systolic hypertension Heesen, Willem Frederik
University of Groningen Isolated systolic hypertension Heesen, Willem Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationHypertension, Antihypertensive Treatment, and Sudden Coronary Death. The Framingham Study WILLIAM B. KANNEL, L. ADRIENNE CUPPLES, RALPH B.
Hypertension, Antihypertensive Treatment, and Sudden Coronary Death The Framingham Study WILLIAM B. KANNEL, L. ADRIENNE CUPPLES, RALPH B. AND JOSEPH STOKES IE D'AGOSTINO, SUMMARY During 30 years of follow-up,
More informationGlobal Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH
Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor
More informationRISE, FALL AND RESURRECTION OF RENAL DENERVATION. Michael A. Weber, MD State University of New York Downstate College of Medicine
RISE, FALL AND RESURRECTION OF RENAL DENERVATION Michael A. Weber, MD State University of New York Downstate College of Medicine Michael Weber, Disclosures Research/Trial Commitments and Consulting: Boston
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationHEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.
OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents
More informationJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 10, 2014 ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 1, 214 ª 214 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 735-197/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jacc.214.6.1186
More informationEpidemiological Evidence for Radiation-induced induced Circulatory Diseases Non-occupational occupational Exposure
Epidemiological Evidence for Radiation-induced induced Circulatory Diseases Non-occupational occupational Exposure Richard Wakeford Dalton Nuclear Institute, The University of Manchester, UK and Mark P
More informationA comparison of diabetic and nondiabetic subjects
Pathophysiology/Complications O R I G I N A L A R T I C L E The Aging of Elastic and Muscular Arteries A comparison of diabetic and nondiabetic subjects JAMES D. CAMERON, MD, MENGSC 1 CHRISTOPHER J. BULPITT,
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial
1 ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Davis BR, Piller LB, Cutler JA, et al. Circulation 2006.113:2201-2210.
More informationThe Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease
Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031
More informationEarly-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study
Early-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study The Harvard community has made this article openly available. Please
More informationJ-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial
J-curve Revisited An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial Sripal Bangalore, MD, MHA, Franz H Messerli, MD, Chuan-Chuan Wun, PhD, Andrea L. Zuckerman,
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More information